Sigachi Industries has informed that the company’s one of India’s leading players in pharmaceutical excipients, APIs, and specialty ingredients, is set to strengthen its scientific and technical capabilities with the commencement of operations at its newly established R&D Center in Hyderabad. Positioned as a critical pillar of the company’s innovation strategy, this R&D Center will drive end-to-end API development—from lab-scale innovation to commercialization and global regulatory filings. A press release to this extent is enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.50 |
| Dr. Reddys Lab | 1233.20 |
| Cipla | 1232.00 |
| Zydus Lifesciences | 937.70 |
| Lupin | 2327.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: